Claire Harrison

Trials

Studies that name Claire Harrison as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:28 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT04116502 · MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera

  University of Birmingham · recruiting · Polycythemia Vera · principal investigator
• Ph3
  NCT01259856 · Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

  Ronald Hoffman · completed · High Risk Polycythemia Vera, High Risk Essential Thrombocythemia · study chair
• N/A
  NCT00175838 · Primary Thrombocythaemia 1 Trial

  University of Cambridge · completed · Thrombocythemia, Myeloproliferative Disorder · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 00:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells
  P01CA108671 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ronald Hoffman · fiscal years 2006 to 2026
  Named on NCT01259856